…
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; P84 System, a product activator consisting of PhytoPower 1 and PhytoPower 2 that contains probiotics, prebiotics, postbiotics, digestive enzymes, and superfood blends designed to support gut health; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
LifeVantage Corporation is a U.S. direct-selling company that sells nutritional supplements and personal-care products through a global network of distributors. Growth drivers include product innovation, international expansion and rising consumer interest in preventive health, which may support recurring sales. Investors may view the company as having an established sales infrastructure and potential for repeat revenue.
Main risks are reliance on a network-marketing model exposed to regulatory and reputational scrutiny, strong competition, and execution risk in distributor recruitment and international growth.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Income before tax | 6.07M | 12.24M | 4.35M | 4.00M | 4.69M |
| Net income | 5.07M | 9.80M | 2.94M | 2.54M | 3.12M |
| Selling general administrative | 58.42M | 69.21M | 68.47M | 71.06M | 63.42M |
| Selling and marketing expenses | 77.09M | - | 85.92M | 94.69M | 97.26M |
| Gross profit | 141.61M | 183.67M | 158.72M | 170.01M | 168.26M |
| Reconciled depreciation | 2.77M | 3.16M | 3.58M | 3.58M | 5.05M |
| Ebit | 6.07M | 12.24M | 4.35M | 0.68M | 1.86M |
| Ebitda | 8.84M | 15.40M | 7.93M | 4.26M | 6.91M |
| Depreciation and amortization | 2.77M | 3.16M | 3.58M | 3.58M | 5.05M |
| Non operating income net other | - | - | - | -0.46M | - |
| Operating income | 6.10M | 12.20M | 4.33M | 4.26M | 1.86M |
| Other operating expenses | 176.49M | 216.33M | 195.83M | 209.14M | 198.78M |
| Interest expense | - | - | - | 0.20M | 0.01M |
| Tax provision | 0.99M | 2.44M | 1.41M | 1.46M | 1.57M |
| Interest income | 0.16M | 0.43M | 0.43M | 0.20M | - |
| Net interest income | 0.16M | 0.43M | 0.43M | 0.20M | -0.01M |
| Income tax expense | 0.99M | 2.44M | 1.41M | 1.46M | 1.57M |
| Total revenue | 182.59M | 228.53M | 200.16M | 213.40M | 206.36M |
| Total operating expenses | 135.51M | 171.47M | 154.39M | 165.75M | 160.69M |
| Cost of revenue | 40.97M | 44.86M | 41.44M | 43.39M | 38.10M |
| Total other income expense net | -0.03M | 0.04M | 0.02M | -0.46M | 2.83M |
| Net income from continuing ops | 5.07M | 9.80M | 2.94M | 2.54M | 3.12M |
| Net income applicable to common shares | - | - | - | 2.54M | 3.12M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Total assets | 62.11M | 71.96M | 60.30M | 66.12M | 70.71M |
| Intangible assets | 3.06M | 0.24M | 0.32M | 0.46M | 0.59M |
| Other current assets | 4.22M | 6.09M | 2.44M | 4.75M | 6.96M |
| Total liab | 28.52M | 37.32M | 34.31M | 31.47M | 39.19M |
| Total stockholder equity | 33.59M | 34.64M | 25.99M | 34.65M | 31.52M |
| Other current liab | 13.14M | 17.39M | 10.89M | 13.75M | 15.59M |
| Common stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Capital stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Retained earnings | -103.46M | -104.15M | -108.74M | -98.31M | -98.44M |
| Other liab | - | - | - | 0.30M | 0.31M |
| Good will | 0.47M | 0.00M | - | - | - |
| Other assets | - | - | - | 3.56M | 2.62M |
| Cash | 14.92M | 20.20M | 16.89M | 21.61M | 20.19M |
| Total current liabilities | 20.23M | 27.22M | 22.31M | 19.61M | 25.73M |
| Current deferred revenue | - | 0.71M | 0.86M | 0.83M | 0.08M |
| Net debt | -5.05M | -8.52M | -3.27M | -8.52M | -4.43M |
| Short term debt | 1.94M | 1.87M | 1.81M | 1.52M | 2.60M |
| Short long term debt total | 9.87M | 11.68M | 13.61M | 13.09M | 15.76M |
| Other stockholder equity | 138.92M | 139.96M | 136.64M | 134.31M | 131.07M |
| Property plant equipment | - | - | - | 9.09M | 20.54M |
| Total current assets | 38.30M | 50.89M | 37.65M | 44.28M | 46.96M |
| Long term investments | - | - | - | - | 0.00M |
| Net tangible assets | - | - | - | 34.19M | 30.93M |
| Net receivables | 2.99M | 3.93M | 3.26M | 1.85M | 5.09M |
| Inventory | 16.17M | 20.67M | 15.05M | 16.07M | 16.47M |
| Accounts payable | 5.16M | 5.06M | 6.29M | 3.50M | 7.46M |
| Accumulated other comprehensive income | -1.87M | -1.18M | -1.92M | -1.36M | -1.12M |
| Common stock total equity | - | - | - | 0.00M | - |
| Retained earnings total equity | - | - | - | -98.31M | - |
| Non currrent assets other | 0.64M | 0.60M | 0.68M | 0.57M | 1.33M |
| Non current assets total | 23.81M | 21.06M | 22.65M | 21.84M | 23.75M |
| Capital lease obligations | 9.87M | 11.68M | 13.61M | 13.09M | 15.76M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Investments | - | -1.37M | -2.25M | -3.06M | -1.53M |
| Change to liabilities | - | - | - | -4.95M | 0.82M |
| Total cashflows from investing activities | -7.31M | -1.37M | -2.25M | -3.06M | -1.53M |
| Net borrowings | 0.00M | 0.00M | - | - | - |
| Total cash from financing activities | -7.78M | -7.60M | -14.42M | -2.36M | -8.95M |
| Change to operating activities | - | - | - | -1.25M | -2.03M |
| Net income | 5.07M | 9.80M | 2.94M | 2.54M | 3.12M |
| Change in cash | -5.28M | 3.31M | -4.72M | 1.42M | -2.98M |
| Begin period cash flow | 20.20M | 16.89M | 21.61M | 20.19M | 23.17M |
| End period cash flow | 14.92M | 20.20M | 16.89M | 21.61M | 20.19M |
| Total cash from operating activities | 10.24M | 11.88M | 12.20M | 6.83M | 7.96M |
| Depreciation | 2.77M | 3.16M | 3.58M | 3.58M | 5.05M |
| Other cashflows from investing activities | -3.74M | 0.00M | 0.00M | 0.01M | - |
| Dividends paid | 2.34M | 2.07M | 6.94M | -1.59M | -0.38M |
| Change to inventory | 2.02M | -5.22M | 0.66M | 0.06M | -1.19M |
| Change to account receivables | -0.55M | -0.56M | -1.50M | 1.56M | -0.61M |
| Sale purchase of stock | -2.04M | -3.15M | -7.65M | -1.02M | -9.08M |
| Other cashflows from financing activities | -3.63M | -2.66M | -0.10M | 0.20M | 0.13M |
| Change to netincome | - | - | - | 1.52M | 3.89M |
| Capital expenditures | 3.57M | 1.37M | 2.25M | 3.07M | 1.53M |
| Change receivables | - | - | - | 1.56M | - |
| Cash flows other operating | - | - | - | 2.52M | - |
| Cash and cash equivalents changes | - | - | - | 1.41M | - |
| Change in working capital | -4.11M | -6.55M | 2.38M | -2.56M | -4.10M |
| Stock based compensation | 2.35M | 5.70M | 3.28M | 3.19M | 1.77M |
| Other non cash items | 3.76M | 1.47M | 1.30M | 1.78M | 2.21M |
| Free cash flow | 6.67M | 10.51M | 9.95M | 3.76M | 6.43M |
Sector: Consumer Defensive Industry: Packaged Foods
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| LFVN Lifevantage Corporation |
0.16 3.51% |
4.72 | 15.85 | 37.45 | 0.42 | 2.34 | 0.40 | 8.28 |
| NSRGF Nestle SA |
- -% |
105.38 | 26.86 | 18.76 | 3.13 | 7.10 | 3.81 | 21.70 |
| NSRGY Nestle SA ADR |
-1.57 1.50% |
103.44 | 26.82 | 18.66 | 3.18 | 7.07 | 3.81 | 21.70 |
| DANOY Danone PK |
-0.17 1.11% |
15.17 | 24.23 | 17.64 | 1.88 | 2.57 | 1.88 | 11.70 |
| GPDNF Danone S.A |
- -% |
75.55 | 20.30 | 14.75 | 1.65 | 2.24 | 1.76 | 10.92 |
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; P84 System, a product activator consisting of PhytoPower 1 and PhytoPower 2 that contains probiotics, prebiotics, postbiotics, digestive enzymes, and superfood blends designed to support gut health; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.
3300 North Triumph Boulevard, Lehi, UT, United States, 84043
801 432 9000
209
| Name | Title | Year Born |
|---|---|---|
| Mr. Steven R. Fife | Pres, CEO & Director | 1961 |
| Mr. Carl A. Aure | Chief Financial Officer | 1973 |
| Mr. Matthew Cooley | Chief Operating Officer | 1973 |
| Ms. Alissa Neufeld | Gen. Counsel & Corp. Sec. | 1979 |
| Ms. Julie Boyster | Chief Marketing Officer | 1985 |
| Mr. Eric E. Marchant | VP of Compliance | NA |
| Chris Taylor | Director of Communications | NA |
| Ms. Michelle Oborn-Virchow | Sr. VP of HR | 1980 |
| Ms. Calli Mott | Sr. VP of Distributor Experience | NA |
| Mr. Dave Fleming | Sr. VP of Sales | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.